
Two documents that will be of interest to those attending the IIMHL Leadership Exchange are the following:
Te Puawaitanga: Maori Mental Health National Strategic Framework , which includes additional links to other Maori Health Publications, and A Pacific Perspective on the NZ Mental Health Classification and Outcomes Study (Microsoft Word format),
prepared for the Mental Health Commission by Fuimaono Karl Pulotu-Endemann, Magila Annandale and Annette Instone provides a Pacific perspective on the policy implications arising from the New Zealand Mental Health Classification and Outcomes Study (CAOS). The paper summarises the CAOS evidence focussing on Pacific-specific information.
Friday, February 11, 2005
Team Approach Studied in Treating Depressed Teens (California) Daily News story reprinted at
MentalHelpNet - "Ventura County doctors, nurses and therapists participated in a new study which looked at the benefits of a team approach in treating depressed teens. Ventura County Medical Center and Ventura County Behavioral Health participated in the UCLA-led study, which also includes the Rand Corp. and Kaiser Permanente Medical Center Los Angeles."
Zyprexa and Zyrtec Substitution Errors May Lead to Adverse Events, Relapse of Schizophrenia or Bipolar Disorder A
Medscape Alert - "The U.S. Food and Drug Administration (FDA) and Eli Lilly & Co. have notified healthcare professionals via letter of reports of medication dispensing or prescribing errors involving olanzapine (Zyprexa, made by Eli Lilly & Co.) and ceterizine HCl (Zyrtec, made by Pfizer, Inc.), according to an alert sent yesterday from MedWatch, the FDA's safety information and adverse event reporting program. The medication errors included instances of ceterizine HCl substitution for prescribed olanzapine (and vice versa), which could lead to adverse events and potential relapse in patients with schizophrenia or bipolar disorder." [Viewing
Medscape resources requires registration, which is free].
Herb as good as depression drug BBC story - "A German study has added weight to the argument that a herbal remedy is an effective treatment for depression. Researchers compared the effectiveness of St John's wort to anti-depressant drug paroxetine in treating moderate and severe depression. The team found half of those with the condition improved when given the herb, compared with a third using the drug, the British Medical Journal reported. UK experts said the study of 244 people should be treated with caution. The study also found patients on paroxetine - also known as Seroxat - suffered more side effects."
Social Support May Stave Off Depression in Women Reuters Health story at
Yahoo - "Feeling loved and supported by family and friends appears to protect women -- but not men -- from major depression, new research reports. In a study of more than 1,000 opposite sex twin pairs, investigators found that women who felt they had relatively little social support had a higher risk of major depression, a condition that affects women more than men. The perception of social support had a much smaller influence on men's risk of depression, the authors report in the
American Journal of Psychiatry."
Mental Health Advocates Concerned About TennCare Changes WTVF story - "Mental health advocates said Thursday they’re concerned TennCare changes could mean more people with mental illnesses will end up on the streets or in jail. Current studies show one in five inmates have some kind of mental illness. Advocates said that number will grow if people don't get the medicine and services they need. Mental health experts from across the state met in Nashville Thursday. They're searching for ways to soften the blow when 100,000 people with mental illness lose benefits."
Copyright 2003 © Bill Davis.
IIMHL Update is a project done in collaboration with MHCA and
the Centre
for Community Change International. IIMHL Update is powered by Radio Userland.